A Pivotal Study of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T)

Clinical trial NCT06673056 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06673056
Sponsor: IntraBio Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Ataxia-Telangiectasia Ataxia-Telangiectasia (A-T)

Start date: 2025-03-18
Primary completion: 2027-12-31
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.